Insulet Corp: Form 10-Q for the period ended Sep 30, 2015
Filed with the SEC on Nov 6, 2015 and accepted by EDGAR at Nov 6, 2015, 16:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2015-07-01 to 2015-09-30 | $51.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2015-01-01 to 2015-09-30 | $121.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2015-07-01 to 2015-09-30 | $35.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2015-01-01 to 2015-09-30 | $102.8m | us-gaap:GrossProfit |
| Research and development | 3 months2015-07-01 to 2015-09-30 | $10.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2015-01-01 to 2015-09-30 | $30.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2015-07-01 to 2015-09-30 | −$15.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2015-01-01 to 2015-09-30 | −$36.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2015-07-01 to 2015-09-30 | $62.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2015-01-01 to 2015-09-30 | $151.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-07-01 to 2015-09-30 | −$18.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2015-01-01 to 2015-09-30 | −$46.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-07-01 to 2015-09-30 | −$0.33 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2015-01-01 to 2015-09-30 | −$0.81 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2015-01-01 to 2015-09-30 | $6.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2015-01-01 to 2015-09-30 | $7.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2015-09-30 | $145.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-30 | $194.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-30 | $293.1m | us-gaap:Assets |
| Current liabilities | At period end2015-09-30 | $59.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-09-30 | $238.0m | us-gaap:Liabilities |
| Long-term debt | At period end2015-09-30 | $173.9m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2015-09-30 | $55.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-15-000066. Last ingested by Listed: Nov 14, 2026, 12:01 ET. Listed shows no prices and gives no investment advice.